Ambry Genetics has completed its one millionth DNA/RNA genetic test, highlighting increased adoption of RNA-enhanced diagnostics for hereditary cancer and rare diseases, according to the company.
Read More
The company will process clinical samples for Path Fertility’s NOA Guide, an epigenetic test designed to inform surgical decision-making for men with non-obstructive azoospermia.
Read More
The test detects Borrelia bacteria directly from skin samples at tick bite sites.
Read More
Researchers at Baylor College of Medicine have identified four new protein markers that improve detection of triple-negative breast cancer cells in blood, potentially enhancing the accuracy of liquid biopsy tests, according to a recent study.
Read More
bioMérieux has acquired Accellix for about €35 million, adding rapid, automated flow cytometry to its pharmaceutical quality control portfolio for cell and gene therapy manufacturing.
Read More